Karuna Garg

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. doi Strategies for distinguishing low-grade endometrioid and serous carcinomas of endometrium
    Karuna Garg
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Adv Anat Pathol 19:1-10. 2012
  2. doi Low-grade serous neoplasms of the ovary with transformation to high-grade carcinomas: a report of 3 cases
    Karuna Garg
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Gynecol Pathol 31:423-8. 2012
  3. doi Morphologic features of uterine leiomyomas associated with hereditary leiomyomatosis and renal cell carcinoma syndrome: a case report
    Karuna Garg
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Am J Surg Pathol 35:1235-7. 2011
  4. doi Pathologic scoring of PTEN immunohistochemistry in endometrial carcinoma is highly reproducible
    Karuna Garg
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Gynecol Pathol 31:48-56. 2012
  5. doi Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma
    Robert A Soslow
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Mod Pathol 25:625-36. 2012
  6. pmc BRCA1 immunohistochemistry in a molecularly characterized cohort of ovarian high-grade serous carcinomas
    Karuna Garg
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Am J Surg Pathol 37:138-46. 2013
  7. doi Histologic evaluation of prophylactic hysterectomy and oophorectomy in Lynch syndrome
    Yevgeniy Karamurzin
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Am J Surg Pathol 37:579-85. 2013
  8. doi BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer
    Rachel N Grisham
    Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Cancer 119:548-54. 2013
  9. doi The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma
    Edward J Tanner
    Department of Surgery, Gynecology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10068, USA
    Gynecol Oncol 123:548-52. 2011
  10. doi Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset
    Karuna Garg
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Am J Surg Pathol 33:1869-77. 2009

Collaborators

Detail Information

Publications20

  1. doi Strategies for distinguishing low-grade endometrioid and serous carcinomas of endometrium
    Karuna Garg
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Adv Anat Pathol 19:1-10. 2012
    ..We will discuss clinical, morphologic, and immunohistochemical differences between the 2 entities and provide practical tips for practicing pathologists when confronted with this differential diagnosis...
  2. doi Low-grade serous neoplasms of the ovary with transformation to high-grade carcinomas: a report of 3 cases
    Karuna Garg
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Gynecol Pathol 31:423-8. 2012
    ..Occasional low-grade serous tumors of the ovary may transform to high-grade carcinomas, which can occur many years after initial diagnosis. The presence of a high-grade component significantly worsens patient outcomes...
  3. doi Morphologic features of uterine leiomyomas associated with hereditary leiomyomatosis and renal cell carcinoma syndrome: a case report
    Karuna Garg
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Am J Surg Pathol 35:1235-7. 2011
    ..Subsequent testing confirmed a fumarate hydratase mutation. The presence of above-described nuclear features in uterine leiomyomas should raise the possibility of HLRCC...
  4. doi Pathologic scoring of PTEN immunohistochemistry in endometrial carcinoma is highly reproducible
    Karuna Garg
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Int J Gynecol Pathol 31:48-56. 2012
    ..Our study shows that evaluation of PTEN loss by immunohistochemistry is highly reproducible with the application of standard immunohistochemical techniques and simple scoring criteria...
  5. doi Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma
    Robert A Soslow
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Mod Pathol 25:625-36. 2012
    ..60 (95% CI, 0.32-0.84) and a negative predictive value of 1.0 (95% CI, 0.63-1.0)). These preliminary data indicate potential strong associations between morphology and genotype in high-grade serous carcinomas...
  6. pmc BRCA1 immunohistochemistry in a molecularly characterized cohort of ovarian high-grade serous carcinomas
    Karuna Garg
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Am J Surg Pathol 37:138-46. 2013
    ....
  7. doi Histologic evaluation of prophylactic hysterectomy and oophorectomy in Lynch syndrome
    Yevgeniy Karamurzin
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Am J Surg Pathol 37:579-85. 2013
    ..Prophylactic hysterectomy allows detection of early lesions in LS; these lesions appear to be small and focal. This small series of prophylactic hysterectomies may provide some clues about LS-associated endometrial carcinogenesis...
  8. doi BRAF mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer
    Rachel N Grisham
    Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Cancer 119:548-54. 2013
    ..In the current study, the authors sought to determine whether BRAF or KRAS mutation status was associated with disease stage and/or histology in patients with SB and LGS ovarian cancer...
  9. doi The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma
    Edward J Tanner
    Department of Surgery, Gynecology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10068, USA
    Gynecol Oncol 123:548-52. 2011
    ..The objective of this study was to assess the role of cytoreductive surgery in patients with stage IIIC-IVB uterine CS...
  10. doi Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset
    Karuna Garg
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Am J Surg Pathol 33:1869-77. 2009
    ..Although young EC patients are at increased risk for synchronous endometrioid ovarian carcinomas, this does not seem to be associated with MMR loss...
  11. doi Incidence of lymph node and adnexal metastasis in endometrial stromal sarcoma
    Lisa A dos Santos
    Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Gynecol Oncol 121:319-22. 2011
    ..To determine the incidence of adnexal and lymph node (LN) metastasis in newly diagnosed endometrial stromal sarcoma (ESS)...
  12. doi High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes
    Edward J Tanner
    Department of Surgery, Gynecology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Gynecol Oncol 127:27-31. 2012
    ..Data regarding management are limited. We aimed to describe disease stage, response to treatment, and survival outcomes among patients with HGUS at our institution...
  13. doi Endosalpingiosis in axillary lymph nodes: a possible pitfall in the staging of patients with breast carcinoma
    Adriana D Corben
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Am J Surg Pathol 34:1211-6. 2010
    ..Morphologic identification of ciliated cells and "peg" cells is most helpful to recognize this benign inclusion, and positive immunoreactivity for WT1 and/or PAX8 can be used to support the diagnosis...
  14. doi Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms
    Laura J Tafe
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Mod Pathol 23:781-9. 2010
    ..These tumors can occur in young women, may be associated with microsatellite instability and behave in a clinically aggressive manner...
  15. doi p53 overexpression in morphologically ambiguous endometrial carcinomas correlates with adverse clinical outcomes
    Karuna Garg
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Mod Pathol 23:80-92. 2010
    ....
  16. ncbi Pseudoneoplastic proliferation of histiocytes with paclitaxel-induced ultrastructural changes in a mastectomy specimen
    Luciano B Lemos
    Department of Pathology, University of Texas Health Science Center at Houston, Medical School, Lyndon B Johnson Hospital, Houston, TX 77026, USA
    Ann Diagn Pathol 8:299-304. 2004
    ..The treated breast carcinoma cells were tubulin-positive but the proliferating histiocytes were tubulin-negative...
  17. doi Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities
    Karuna Garg
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Am J Surg Pathol 33:925-33. 2009
    ..Tumor morphology (TM-MMR) along with IHC-MMR enhances the detection of EC patients at risk of HNPCC...
  18. doi Endometrial carcinoma in women aged 40 years and younger
    Karuna Garg
    From the Department of Pathology, University of California San Francisco Dr Garg and the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York Dr Soslow
    Arch Pathol Lab Med 138:335-42. 2014
    ..Endometrial carcinoma is a disease of older postmenopausal women, and is relatively uncommon in patients younger than 40 years. Endometrial carcinomas in this age group may be familial, associated with Lynch syndrome, or sporadic...
  19. doi Histologically bland "extremely well differentiated" thyroid carcinomas arising in struma ovarii can recur and metastasize
    Karuna Garg
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Int J Gynecol Pathol 28:222-30. 2009
    ..The hormonal milieu during pregnancy may lead to progression of malignant SO and such patients should be closely followed, particularly if their treatment consists of cystectomy alone...
  20. ncbi Adenomatoid tumor of the adrenal gland: a clinicopathologic study of 3 cases
    Karuna Garg
    Department of Pathology, Health Science Center, University of Texas, Houston, TX 77030 4009, USA
    Ann Diagn Pathol 9:11-5. 2005
    ..In our experience, the key to the diagnosis of this rare benign tumor is to consider adenomatoid tumor in the differential diagnosis of any glandular tumor occurring in the adrenal gland...